These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 6859228

  • 1. Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue.
    Huey R, Bloor CM, Kawahara MS, Hugli TE.
    Am J Pathol; 1983 Jul; 112(1):48-60. PubMed ID: 6859228
    [Abstract] [Full Text] [Related]

  • 2. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP, Hugli TE, Bloor CM.
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.
    Hoffmann T, Böttger EC, Baum HP, Messner M, Hadding U, Bitter-Suermann D.
    Clin Exp Immunol; 1988 Mar; 71(3):486-92. PubMed ID: 3260158
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Human C5a des Arg increases vascular permeability.
    José PJ, Forrest MJ, Williams TJ.
    J Immunol; 1981 Dec; 127(6):2376-80. PubMed ID: 6170701
    [Abstract] [Full Text] [Related]

  • 8. Decreased synthesis of serum carboxypeptidase N (SCPN) in familial SCPN deficiency.
    Mathews KP, Curd JG, Hugli TE.
    J Clin Immunol; 1986 Jan; 6(1):87-91. PubMed ID: 3958137
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. C4a: the third anaphylatoxin of the human complement system.
    Gorski JP, Hugli TE, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5299-302. PubMed ID: 291947
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The active site of human C4a anaphylatoxin.
    Hugli TE, Kawahara MS, Unson CG, Molinar-Rode R, Erickson BW.
    Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
    [Abstract] [Full Text] [Related]

  • 13. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
    Meuer S, Hugli TE, Andreatta RH, Hadding U, Bitter-Suermann D.
    Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
    [Abstract] [Full Text] [Related]

  • 14. Aggregate anaphylaxis and carboxypeptidase N.
    Ryan JW, Berryer P, Hart MA, Ryan US.
    Adv Exp Med Biol; 1986 Dec; 198 Pt A():435-43. PubMed ID: 3028062
    [Abstract] [Full Text] [Related]

  • 15. Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses.
    Morgan EL, Weigle WO, Hugli TE.
    J Exp Med; 1982 May 01; 155(5):1412-26. PubMed ID: 6978374
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.